SCHEMBL9131013

SCHEMBL9131013

COc1ccccc1OC1CCN(CCCCCN2C(=O)c3ccccc3S2(O)O)C1

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 8/20 0.51
▸ HTR1A P08908 7/20 0.51
▸ HTR2A P28223 5/20 0.51
▸ HTR7 P34969 5/20 0.51
▸ HTR6 P50406 5/20 0.51
▸ DRD4 P21917 1/20 0.49
▸ DRD5 P21918 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ ADRA1D P25100 3/20 0.41
▸ ADRA1A P35348 3/20 0.41
▸ ADRA1B P35368 3/20 0.41
▸ CHRM2 P08172 1/20 0.40
▸ CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9131371 0.99 HTR1A (0.51) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9134171 0.97 HTR1A (0.54) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9131814 0.93 HTR1A (0.47) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9131046 0.90 HTR1A (0.54) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9131003 0.90 DRD2 (0.64) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9244705 0.89 HTR1A (0.64) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9131364 0.89 HTR1A (0.64) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9129056 0.89 HTR1A (0.64) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9129953 0.89 HTR1A (0.52) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL9131871 0.88 DRD2 (0.43) DRD2HTR1AHTR2AHTR7HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5453437-A 1,3-disubstituted pyrrolidines BAYER AKTIENGESELLSCHAFT (DE) 1995-09-26 — — US disclosed
US-5274097-A A 1-N-heterocyclic alkylene-3-carbo or heterocyclic ring oxypyrrolidine derivative BAYER AKTIENGESELLSCHAFT (DE) 1993-12-28 — — US disclosed
US-5037841-A For treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1991-08-06 — — US disclosed
Send feedback